|
May 3
|
ANI Pharmaceuticals (ANIP) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
|
|
May 3
|
Blueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises
|
|
May 3
|
Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?
|
|
May 2
|
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
|
|
May 1
|
ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences
|
|
May 1
|
GSK Beats Q1 Earnings & Sales Estimates, Ups 2024 Guidance
|
|
May 1
|
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
|
|
Apr 26
|
Sage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates
|
|
Apr 18
|
ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET
|
|
Apr 18
|
Sage (SAGE) Down 20% on Parkinson's Study Missing Primary Goal
|
|
Apr 17
|
GSK Announces FDA Acceptance of New Meningococcal Jab BLA
|
|
Apr 16
|
Aptevo (APVO) Stock Plummets 79% in a Week: Here's Why
|
|
Apr 16
|
Marinus (MRNS) Down 83% on Lead Drug Falling Short in Seizure Study
|
|
Apr 15
|
Enlivex (ENLV) Stock Plummets 51% in a Week: Here's Why
|
|
Apr 15
|
Why ANI (ANIP) is Poised to Beat Earnings Estimates Again
|
|
Apr 12
|
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) is favoured by institutional owners who hold 64% of the company
|
|
Apr 10
|
ANI Pharmaceuticals (ANIP) Stock Moves -0.13%: What You Should Know
|
|
Apr 10
|
Moderna (MRNA) Up 6% on Upbeat Data From Cancer Jab Study
|
|
Apr 10
|
Syros (SYRS) Up on FDA Fast Track Tag for Tamibarotene in AML
|
|
Apr 9
|
Vincerx (VINC) Tumbles on Results From Cancer Therapy Study
|